George Medicines announces FDA approval of WIDAPLIK™ (telmisartan, amlodipine and indapamide), a new single pill combination treatment for hypertension in adults, including initial treatment ...

HemiClor (chlorthalidone) is indicated for the treatment of hypertension to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily ...

Chlorthalidone, a thiazide-like diuretic, has been studied extensively over several decades in the treatment of hypertension. It is recognized in the 2017 ACC/AHA Guideline for the Prevention ...

The FDA has approved HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood pressure.

A secondary analysis of the DCP shows that, compared with hydrochlorothiazide, chlorthalidone significantly increases the risk of kidney stones — but only among those with prior stones.

Meeting Coverage > NKF One Diuretic May Be Better for Hypertensive Patients With Kidney Stone History — Secondary analysis compared chlorthalidone and hydrochlorothiazide by Kristen Monaco ...

New Delhi: Windlas Biotech has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) to conduct the bioequivalence study of the ...

Chlorthalidone is not superior to hydrochlorothiazide in terms of kidney outcomes, but it is associated with an increased risk for hypokalemia, according to a recent study.

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has opined Windlas Biotech to submit a fresh bioequivalence (BE) protocol with a ...

Chlorthalidone and hydrochlorothiazide are diuretics used to lower blood pressure. Learn more about the primary differences between these two medications.

Zydus Lifesciences receives US FDA approval to market Azilsartan Medoxomil, Chlorthalidone tablets Azilsartan and chlorthalidone is an angiotensin II receptor blocker (ARB) and a thiazide-like ...